IP Library Granted Patent US 9,949,775
Granted Patent B2
US 9,949,775 · App. 15/435,977 · Granted Apr 24, 2018

Hammer toe implant with expansion portion for retrograde approach

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,949,775
App. No.
15/435,977
Granted
Apr 24, 2018
Kind
B2
Abstract

A system includes and implant and an elongate device. The implant includes a first bone engaging portion and a flexible portion coupled to an end of the first bone engaging portion at an engagement portion. The flexible portion is configured to be compressed toward a longitudinal axis defined by the flexible portion. The elongate device includes an engagement end that is sized and configured to engage the engagement portion of the implant.

Claims (19)

1. A system, comprising:

an implant including

a bone engaging portion,

a flexible portion coupled to an end of the bone engaging portion at an engagement portion, the flexible portion configured to be compressed toward a longitudinal axis defined by the flexible portion; and

an elongate device including an engagement end sized and configured to engage the engagement portion of the implant; wherein said engagement portion extends radially away from the longitudinal axis defined by the flexible portion and defines at least one notch that is sized and configured to receive a tab of the engagement end of the elongate device and further including at least one prominence extending radially away from the longitudinal axis that is sized and configured to be received within a notch defined by the engagement end.

2. The system of claim 1 , wherein the bone engaging portion of the implant is threaded.

3. The system of claim 1 , wherein the engagement end of the elongate device is at least partially hollow such that the flexible portion of the implant can be received therein.

4. The system of claim 1 wherein the engagement portion defines a plurality of notches, each of the plurality of notches sized and configured to receive a respect one of a plurality of tabs of the engagement end.

5. The system of claim 1 wherein the elongate device is hollow, the system further comprising an elongate core sized and configured to be received within the elongate device.

6. The system of claim 5 , wherein the elongate core includes at least one fin extending from a first end, the at least one fin sized and configured to be received within a respective slot defined by the flexible portion of the implant.

7. The system of claim 6 , wherein the slot defined by the flexible portion of the implant is defined between a pair of prongs of the implant.

8. A system, comprising:

an implant including

a threaded portion terminating at an engagement portion,

a plurality of prongs coupled to, and extending away from, the engagement portion, the plurality of prongs defining at least one slot therebetween; and

an elongate device including an engagement end and defining a hole at the engagement end, the hole at the engagement end sized and configured to receive the plurality of prongs therein; wherein said engagement portion extends radially away from a longitudinal axis defined by the plurality of prongs and defines at least one notch that is sized and configured to receive a tab of the engagement end of the elongate device and further including at least one prominence extending radially away from the longitudinal axis that is sized and configured to be received within a notch defined by the engagement end.

9. The system of claim 8 , wherein the engagement portion of the implant defines a plurality of notches, each of the plurality of notches sized and configured receive a respect one of a plurality of tabs of the engagement end of the elongate device therein.

10. The system of claim 8 wherein the hole extends entirely through the elongate device, the system further comprising an elongate core sized and configured to be received within the hole defined by the elongate device.

11. The system of claim 10 , wherein the elongate core includes at least one fin extending from a first end, the at least one fin sized and configured to be received within the at least one slot defined by the plurality prongs of the implant.

Assignments (2)
RELEASE OF SECURITY INTEREST Recorded Nov 19, 2020
From: MIDCAP FUNDING IV TRUST
To: WRIGHT MEDICAL GROUP N.V.; WRIGHT MEDICAL GROUP, INC.; BIOMIMETIC THERAPEUTICS CANADA, INC.; BIOMIMETIC THERAPEUTICS, LLC; BIOMIMETIC THERAPEUTICS USA, INC.; INBONE TECHNOLOGIES, INC.; ORTHOHELIX SURGICAL DESIGNS, INC.; ORTHOPRO, L.L.C.; SOLANA SURGICAL, LLC; TORNIER US HOLDINGS, INC.; TORNIER, INC.; TROOPER HOLDINGS INC.; WHITE BOX ORTHOPEDICS, LLC; WRIGHT MEDICAL CAPITAL, INC.; WRIGHT MEDICAL TECHNOLOGY, INC.; WRIGHT MEDICAL GROUP INTELLECTUAL PROPERTY, INC.
Reel/Frame 054480/0001 →
SECURITY INTEREST Recorded Jun 4, 2018
From: WRIGHT MEDICAL GROUP N.V.; WRIGHT MEDICAL GROUP, INC.; BIOMIMETIC THERAPEUTICS CANADA, INC.; BIOMIMETIC THERAPEUTICS, LLC; BIOMIMETIC THERAPEUTICS USA, INC.; INBONE TECHNOLOGIES, INC.; ORTHOHELIX SURGICAL DESIGNS, INC.
To: MIDCAP FUNDING IV TRUST, AS AGENT
Reel/Frame 046291/0001 →